Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1056/NEJMe2406408

Type

Journal

N Engl J Med

Publication Date

11/07/2024

Volume

391

Pages

178 - 179

Keywords

Humans, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Drug Approval, Glucagon-Like Peptides, Hypoglycemic Agents, Glucagon-Like Peptide-1 Receptor Agonists, Renal Insufficiency, Chronic, Cardiovascular Diseases, Diabetic Cardiomyopathies, Injections, Subcutaneous, Randomized Controlled Trials as Topic